Tao Ge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Tao Ge has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Gengfan Ye
Department of Neurosurgery, Ningbo Medical Centre Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang, 315040, CHINA
1 shared publicationHao Wang
Department of Neurosurgery, Ningbo Medical Centre Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang, 315040, CHINA
1 shared publicationHongcai Wang
Department of Neurosurgery, Ningbo Medical Centre Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang, 315040, CHINA
1 shared publicationJia Li
Department of Neurosurgery, Ningbo Medical Centre Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang, 315040, CHINA
1 shared publicationJianxiang Jin
Department of Neurosurgery, Ningbo Medical Centre Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang, 315010, CHINA
1 shared publicationKuan Feng
Department of Neurosurgery, Ningbo Medical Centre Lihuili Hospital, No.1111 Jiangnan Road, Yinzhou District, Ningbo, Zhejiang, 315040, CHINA
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by IOP Publishing in Biomedical Materials
- Vol. 20 (1) , 015037
Synthesis and characterization of a novel photothermal hydrogel composite with combined osteogenic and antibacterial activities
Cranial defect repair remains a significant challenge in neurosurgery, and designing material complexes that can support bone regeneration while minimizing complications such as infection and inflammation could help alleviate this clinical challenge. This study presents a photothermal hydrogel complex with a controlled rapid gelation process, PDA-G-A-H, which integrates photothermal polydopamine nanoparticles (PDA NPs) with gentamycin (G) and alendronate acid (A). Furthermore, the incorporation of the injectable hydrogel Pluronic F127 and collagen (H) made this composite hydrogel (PDA-G-A-H) suitable for the multifaceted needs of cranial defects. The PDA-G-A-H hydrogel exhibited superior biocompatibility, as evidenced by high cell viability and minimal hemolysis, making it a safe candidate for biomedical applications. In vitro assessments with MC3T3-E1 cells demonstrated that this hydrogel enhanced mineralization and osteogenic differentiation, and significant upregulation of key osteogenic markers was subsequently detected. The antibacterial activity of the hydrogel against Staphylococcus aureus and Staphylococcus epidermidis was also investigated. The results of the RT‒PCR analysis revealed the potential for inhibiting biofilm formation. The hydrogel composite combines biocompatibility, osteoinductive, and antibacterial potential. It has translational potential for cranial defect repair and other bone regeneration therapies.
- 1 January 2025
- Published by IOP Publishing in Biomedical Materials
- Vol. 20 (1) , 015037
Open AccessSynthesis and characterization of a novel photothermal hydrogel composite with combined osteogenic and antibacterial activities
Cranial defect repair remains a significant challenge in neurosurgery, and designing material complexes that can support bone regeneration while minimizing complications such as infection and inflammation could help alleviate this clinical challenge. This study presents a photothermal hydrogel complex with a controlled rapid gelation process, PDA-G-A-H, which integrates photothermal polydopamine nanoparticles (PDA NPs) with gentamycin (G) and alendronate acid (A). Furthermore, the incorporation of the injectable hydrogel Pluronic F127 and collagen (H) made this composite hydrogel (PDA-G-A-H) suitable for the multifaceted needs of cranial defects. The PDA-G-A-H hydrogel exhibited superior biocompatibility, as evidenced by high cell viability and minimal hemolysis, making it a safe candidate for biomedical applications. In vitro assessments with MC3T3-E1 cells demonstrated that this hydrogel enhanced mineralization and osteogenic differentiation, and significant upregulation of key osteogenic markers was subsequently detected. The antibacterial activity of the hydrogel against Staphylococcus aureus and Staphylococcus epidermidis was also investigated. The results of the RT‒PCR analysis revealed the potential for inhibiting biofilm formation. The hydrogel composite combines biocompatibility, osteoinductive, and antibacterial potential. It has translational potential for cranial defect repair and other bone regeneration therapies.